Research

Over-expression of AhR (aryl hydrocarbon receptor) induces neural differentiation of Neuro2a cells: neurotoxicology study

Eiichi Akahoshi , Seiko Yoshimura and Mitsuko Ishihara-Sugano

Environmental Technology Laboratory, Corporate Research & Development Center, Toshiba Corporation, 1 Komukai-Toshiba cho, Saiwai-ku, Kawasaki 212–8582, Japan

author email corresponding author email

Environmental Health: A Global Access Science Source 2006, 5:24doi:10.1186/1476-069X-5-24

The electronic version of this article is the complete one and can be found online at: http://www.ehjournal.net/content/5/1/24

Received:	10 April 2006
Accepted:	7 September 2006
Published:	7 September 2006

© 2006 Akahoshi et al; licensee BioMed Central Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Background

Dioxins and related compounds are suspected of causing neurological disruption in human and experimental animal offspring following perinatal exposure during development and growth. The molecular mechanism(s) of the actions in the brain, however, have not been fully investigated. A major participant in the process of the dioxin-toxicity is the dioxin receptor, namely the aryl hydrocarbon receptor (AhR). AhR regulates the transcription of diverse genes through binding to the xenobiotic-responsive element (XRE). Since the AhR has also been detected in various regions of the brain, the AhR may play a key role in the developmental neurotoxicity of dioxins. This study focused on the effect of AhR activation in the developing neuron.

Methods

The influence of the AhR on the developing neuron was assessed using the Neuro2a-AhR transfectant. The undifferentiated murine neuroblastoma Neuro2a cell line (ATCC) was stably transfected with AhR cDNA and the established cell line was named N2a-Rα. The activation of exogenous AhR in N2a-Rα cells was confirmed using RNAi, with si-AhR suppressing the expression of exogenous AhR. The neurological properties of N2a-Rα based on AhR activation were evaluated by immunohistochemical analysis of cytoskeletal molecules and by RT-PCR analysis of mRNA expression of neurotransmitter-production related molecules, such as tyrosine hydroxylase (TH).

Results

N2a-Rα cells exhibited constant activation of the exogenous AhR. CYP1A1, a typical XRE-regulated gene, mRNA was induced without the application of ligand to the culture medium. N2a-Rα cells exhibited two significant functional features. Morphologically, N2a-Rα cells bore spontaneous neurites exhibiting axon-like properties with the localization of NF-H. In addition, cdc42 expression was increased in comparison to the control cell line. The other is the catecholaminergic neuron-like property. N2a-Rα cells expressed tyrosine hydroxylase (TH) mRNA as a functional marker of catecholaminergic neurotransmitter production. Thus, exogenous AhR induced catecholaminergic differentiation in N2a-Rα cells.

Conclusion

The excessive activation of AhR resulted in neural differentiation of Neuro2a cells. This result revealed that dioxins may affect the nervous system through the AhR-signaling pathway. Activated AhR may disrupt the strictly regulated brain formation with irregular differentiation occurring rather than cell death.

Background

The aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor belonging to a basic helix-loop-helix/Per-Arnt-Sim (bHLH-PAS) family [1,2]. AhR is activated by a variety of environmental contaminants including polycyclic aromatic hydrocarbons (PAH), planar chlorinated biphenyls (PCB), and halogenated aromatic hydrocarbons (HAH) such as 2, 3, 7, 8, -tetrachlorodibenzo-p-dioxin (TCDD) [3,4]. Several major signal transduction pathways are mediated by the AhR, allowing dioxins to affect diverse biological processes [5,6].

The AhR is activated by binding to ligands, including dioxins, translocates from the cytoplasm to the nucleus and then binds to the consensus sequence known as XRE (xenobiotic responsive element) [7]. XREs are found in the promoter region of a variety of genes. Several phase I and phase II xenobiotic metabolizing enzymes, including cytochrome P-450 (CYP) 1A1, CYP1B1 and glutathione S-transferase (GST) possess multiple XRE sequences in the promoter region, and are the target genes for AhR following binding to the AhR ligands [8-11]. In addition to the xenobiotic or detoxification processes, the ligands of AhR, such as TCDD, also affect the expression of a number of genes involved in cell proliferation (TGF-β, IL-1β and PAI-2), cell cycle regulation (p27 and jun-B) [5,12-14] and inflammation. The AhR pathway may participate in the developmental toxication of dioxins during ontogenesis.

One of the dioxins, TCDD, can also influence the developing brain. After exposure to experimental animals, TCDD was detected in the brain and impaired their learning behavior. Perinatal exposure to TCDD has also been found to remarkably affect learning ability in rats and monkeys [15-17]. However the molecular mechanisms of the action of TCDD in the brain have not been fully elucidated.

The dioxin receptor, namely the AhR, is expressed in various regions of the brain [18,19] during the critical period of brain development [20,21]. In particular, it has been reported that maximal expression of AhR protein was observed during P3–10 [22]. This stage is considered to be the critical period for the growth and maturation of neuroblasts in the cerebellar granular cell layer. These findings imply that the AhR may be involved in the molecular processes of brain development, and may also be related to the developmental neurotoxicity of TCDD. However, it has been very difficult to directly examine the actual role of AhR in the pathway from TCDD to the function during brain development, because an experimental model has not yet been established to investigate AhR function in developing neurons.

The regulation of neurogenesis is key event for controlling brain development. To understand the regulatory mechanisms of neurogenesis, neuroblastoma is widely used as an experimental model. Neuroblastoma usually arises from the proliferation of neural crest-derived precursors resulting in defective differentiation in vivo [23]. Neuroblastoma cells proliferate as undifferentiated cells in standard cell culture, but they have the potential to become neuronal precursors [24,25]. Neuro2a cells are a murine neuroblastoma cell line that has proven to be a useful experimental model for studying some aspects of differentiation mechanism since its differentiation can be controlled by various conditions, such as low serum concentration, retinoic acid and cAMP [26,27]. In the present study, we transfected a neuroblastoma cell line, Neuro2a, with cloned AhR and examined the effect of over-expression of the AhR on these cells. This stable transfectant will be an appropriate experimental model for analyzing the relationships between AhR activation and developmental neurotoxicity.

Methods

Cell cultures

Neuro2a, a murine neuroblastoma cell line, was purchased from American Type Culture Collection, and was routinely grown in Dulbecco's modified Eagle's medium and medium F12 in a 1:1 ratio, supplemented with 10% fetal calf serum. Cells were grown at 37°C in a humidified atmosphere of 5% CO₂/95% air.

Construction of expression vectors

The coding sequence of AhR was obtained by RT-PCR from rat brain RNA with Pyrobest DNA polymerase (TAKARA BIO Inc., Shiga, Japan). PCR primers were designed to contain appropriate restriction sites for subcloning. The sequences of the primers were: 5'-CCCAAGCTTACCATGAGCAGCGGCGCCAACATCA-3' (HindIII) and 5'-CCGCTCGAGAGGAATCCGCTGGGTGTGATATCAG-3' (XhoI). After digestion with HindIII and XhoI, the PCR product was cloned into the mammalian expression vector pcDNA4/V5-His (Invitrogen Japan KK, Tokyo, Japan) digested with HindIII and XhoI. The resulting vector contained the coding sequence of AhR fused to the V5/His tag under the control of cytomegalovirus promoter. Correct insertion of the PCR product was verified by DNA sequencing.

Stable introduction of AhR into the Neuro2a cell line

Neuro2a cells were maintained and grown in Dulbecco's modified Eagle's medium and medium F12 in a 1:1 ratio, supplemented with 10% fetal calf serum. The cells (8 × 10⁴) were transfected with 0.8 μg of constructed plasmid using Lipofectamine 2000 according to the manufacturer's instructions (Invitrogen Japan KK). Cells transfected with a vector without the insert were used as a control. After culturing for 72 h in normal medium, the cells were switched to medium supplemented with 250 μg/ml antibiotic zeocin (Invitrogen Japan KK). The medium was changed every 3 days during selection of viable cells. After 2 weeks, viable cells were isolated using cloning rings. The isolated clones were cultured in medium supplemented with 250 μg/ml zeocin for another 2 weeks and the viable clones were selected for further characterization.

Reverse Transcriptase (RT)-PCR

Total RNA was isolated from cultured cells following a 2-day culture using RNeasy (Qiagen KK, Tokyo, Japan). Rat brain RNA was extracted from 8-week-old Sprague-Dawley rats. The rats were killed by cervical dislocation under ether anesthesia and the brains were dissected.Total RNA was extracted by Quick Prep Total RNA Extraction Kit (GE Healthcare Bio-Sciences Corp. NJ, USA). Total RNA of mouse brains were purchased from ZYAGEN laboratories (CA, USA). These RNAs were reverse-transcribed into cDNA using Superscript II reverse transcriptase (Invitrogen Japan KK). PCR was performed with Ex Taq polymerase (TAKARA BIO Inc.) using gene-specific primers. The primer sequences were as follows: AhR, 5'-CCGTCCATCCTGGAAATTCGAACC -3', 5'-CCTTCTTCATCCGTTAGCGGTCTC; CYP1A1, 5'-TTGCCCTTCATTGGTCACAT-3', 5'-GAGCAGCTCTTGGTCATCAT-3'; AhRR, 5'-CCCAAACTCAATTACTTAGCAGG-3', 5'-GCTTCCAGGGTAGGGCACACAGG-3'; GST, 5'-CCTGGCTGCAGCAGGGGTGGAG-3', 5'-CGGTTTTTGGTCCTGTCTTTTGC-3'; cdc42, 5'-GATACTGCAGGGCAAGAGGA -3', 5'-CAGGCACCCACTTTTCTTTC-3'; TH, 5'-CCACGGTGTACTGGTTCACT-3', 5'-GGCATAGTTCCTGAGCTTGT -3'; Nurr, 5'-CCAATCCGGCAATGACCAG-3', 5'-GTCAGCAAAGCCAGGGATCTTC-3'; Cyclophilin, 5'-GTCTCCTTCGAGCTGTTTGCAG-3', 5'-CCATCCAGCCATTCAGTCTTGG-3'. PCR products were electrophoresed on 3% Nusieve 3:1 agarose gel (TAKARABIO inc.) and then stained with ethidium bromide. The intensities ofthe bands were quantified using ImageJ software [28] and then normalized to those of cyclophilin.

RNA interference

Two siRNAs, si-AhR and scramble, were synthesized (Qiagen KK) and transfected into the cells using RNAiFect according to the manufacturer's instructions (Qiagen KK). The siRNA sequences were: si-AhR, 5'-UCCCACAUCCGCAUGAUUATT-3', 5'-TTAGGGUGUAGGCGUACUAAU-3'; scramble, 5'-UACCCAUCAUGACCCUGAUTT-3', 5'-TTAUGGGUAGUACUGGGACUA-3'. Two days after transfection, total RNA was extracted from the cells and reverse-transcribed with Superscript II reverse transcriptase. The cDNAs were used in real-time PCR as templates for quantification.

Real-Time PCR

AhR, CYP1A1 and cdc42 mRNA expression were quantified in AhR by real-time PCR. The primers used in real-time PCR were the same as those described above. Real-time PCR was carried out with DNA engine (Bio-Rad Japan, Tokyo, Japan) using the DyNAamo SYBR Green qPCR Kit (Finnzymes, Oy, Finland). The PCR conditions were: 95°C for 5 min, 40 cycles of 95°C for 10 s, 58°C for 10 s, and 72°C for 20 s with fluorescence measurements read during each cycle. The expression levels of AhR and CYP1A1 mRNAs were normalized to those of cyclophilin mRNA. The series of measurements was performed four times.

Western Blot analysis

Tissues and cells were homogenized in phosphate buffered saline (PBS) and denatured with SDS. Total protein concentrations were determined by Bio-Rad Protein Assay (Bio Rad Laboratories Inc., USA). Proteins (30 μg/lane) were fractionated on 10% SDS-PAGE and transferred to PVDF membrane (Millipore MA, USA). Membranes were blocked with Block Ace (Dainippon Seiyaku, Osaka, Japan) and then incubated with an anti-AhR mouse monoclonal antibody (1:500; Affinity BioReagents, CO, USA). After incubation with the primary antibody, the membrane was washed three times with tris-buffered saline (TBS). The blots were subsequently exposed to an alkaline phosphatase-conjugated rabbit anti-mouse IgG (1:1000; Bio-Rad). The blots were visualized with BCIP-NBT substrate solution (Kirkegaard & Perry Laboratories, Inc. MD, USA).

Immunofluorescence microscopy

After being cultured for 2 days, the cells were rinsed with phosphate-buffered saline (PBS) and fixed with methanol for 25 min at 4°C. They were incubated with monoclonal anti-phosphorylated neurofilament 200-kDa antibody (Sigma, MO, USA). After washing five times with PBS, the cells were treated with FITC-conjugated goat anti-mouse IgG (CHEMICON International Inc. CA, USA) and were then subjected to fluorescence microscopy.

Cell proliferation assay

Cells (1.0 × 10³) were seeded in each well of a 96-well flat bottom culture plate and cultured for 1, 3 and 7 days. Cell proliferation was measured by Alamar Blue dye reduction assay (Trek Diagmpstic Systems, OH, USA). Briefly, Alamar Blue solution (10% final concentration vol/vol) was added to each well and the plate was incubated for 2h at 37°C. Dye reduction was measured in a Mithras LB940 microplate reader (Berthold Japan, Tokyo, Japan) at 530 nm excitation and at 590 nm emission. Cell proliferation rate was calculated as the fold increases, compared with the value at day 1.

Statistics

All values are presented as the mean ± standard deviation of the mean (S. D.). All experiments were replicated at least three times. Data were analysed using Student's T-test with the Exel software package.

Results

Establishment of Neuro2a-AhR stable transfectant

To investigate the function of AhR in developmental neurotoxicity, we attempted to establish Neuro2a-AhR transfectants. The murine neuroblastoma cell line, Neuro2a, was transfected with AhR cDNA in the expression vector (pcDNA4/V5-His), which includes the V5 epitope and the cytomegalovirus promoter. Seventy-five stably transfected clones were obtained after selection with zeocin. One of the clones, named N2a-Rα, was selected and used in a further series of experiments. Figure 1 shows the morphology of N2a-Rα, compared with control cells transfected with the intact vector (named N2a-Vc) and the parental Neuro2a cells (Neuro2a). Spontaneous neurite outgrowth was observed only in N2a-Rα, but not in N2a-Vc and Neuro2a. Most of the 75 transfectants exhibited similar morphology and displayed spontaneous neurite outgrowth.

Transcriptional activation of exogenous AhR

RT-PCR analysis was performed using mRNA isolated from transfectants to evaluate the expression of AhR mRNA with AhR-specific primers. The AhR primers were designed for rat AhR, but also specifically recognize and amplify mouse AhR under identical PCR conditions (Fig 2A). AhR mRNA was not detected in either the original Neuro2a cells or N2a-Vc cells transfected with the vector that did not contain the insert. On the other hand, AhR mRNA was clearly detected (Fig. 2A) in N2a-Rα. Since the primers for AhR amplify both rat and mouse AhR, these results indicate that N2a-Rα expressed AhR mRNA at a high level and that N2a-Vc expression of AhR was below the detection limit. The expression of AhR in N2a-Rα cells was reflected in the protein levels (Fig. 2B). Although immunoreactivity for AhR was not detected in the N2a-Vc and Neuro2a cells, the protein band corresponding to the molecular weight of AhR was clearly detected in N2a-Rα.

In order to confirm the transcriptional activity of the exogenous AhR in N2a-Rα, we analyzed CYP1A1, GST and AhRR (AhR repressor) mRNA expression as functional markers of AhR [8-11,29]. These genes were reported to be regulated by AhR binding to the XRE. The ligand-activated AhR binds to the XRE sequence in the promoter region of the CYP1A1 gene to activate its expression [30]. As such, CYP1A1, GST and AhRR mRNA would be induced if functional AhR is expressed in N2a-Rα. All mRNA species were detected in N2a-Rα cells with RT-PCR (Fig. 2C). These results suggest that the transfected AhR was expressed and functional in the N2a-Rα cells, even without the application of ligand to the culture medium.

If the AhR stimulated the expression of XRE-mediated genes in N2a-Rα, such as CYP1A1, this expression would be attenuated by suppressing AhR activity. In this context, we attempted to suppress the AhR transcription using RNA interference. Two siRNAs (AhR and scramble, see "Methods" section) were transfected into N2a-Rα cells. Two days after transfection, the expression of AhR and CYP1A1 mRNA was measured by real-time quantitative PCR. As a result, AhR mRNA was decreased about 30% in N2a-Rα cells transfected with AhR siRNA, while the CYP1A1 mRNA level was decreased about 60% (Fig. 3). The expression levels of the AhR and CYP1A1 were not affected by the transfection of the scramble siRNA.

As stated above, the expression of both AhR and CYP1A1 were high in N2a-Rα, and were suppressed with siRNA against AhR. These results suggest that the activation of CYP1A1 was caused by over-expression of the AhR; specifically, the AhR expressed in N2a-Rα is functional as if activated by a ligand. The excess mRNA expressed in N2a-Rα cells might be sufficient for substituting the ligand-activated AhR.

Properties of N2a-Rα neurites

Neurite elongation of the N2a-Rα cells implied their neuronal differentiation. Further analyses were performed to investigate the properties of the neurites that spontaneously elongated from N2a-Rα cells. The N2a-Rα cells (Fig. 1) were stained immunocytochemically with anti-cytoskeletal molecule antibodies. We selected the phosphorylated high molecular weight form (NF-H) as a mature axon marker [24,31]. Phosphorylated NF-H is localized in mature axons, but not in dendrites. N2a-Rα cells and N2a-Vc cells were immunostained with monoclonal anti-phosphorylated neurofilament 200-kDa antibody and FITC-conjugated goat anti-mouse IgG. The neurites exhibited positive immunostaining for phosphorylated NF-H (Fig. 4A). On the other hand, no fluorescent signal was observed after staining with MAP2a and 2b, which are markers of dendrites (data not shown) [32].

The expression of cdc42 mRNA in N2a-Rα was assessed using real-time PCR, and compared to N2a-Vc. The expression of cdc42 mRNA in N2a-Rα was approximately 35% higher than that of N2a-Vc (Fig. 4B). cdc42 is a member of the Rho family of small GTPases and is involved in cytoskeletal reorganization and the subsequent morphological changes in various cell types [33,34]. In PC12 cells, which have been used as a model system for neural differentiation and neurite outgrowth, expression of cdc42 has been reported to promote neurite outgrowth [35]. Recent evidence has supported that cdc42 is essential for the normal development of axons and plays a critical role in axon navigation [36]. Therefore the increased expression of cdc42 in N2a-Rα suggests that the processes elongated from N2a-Rα might be axons.

In addition, we measured cell proliferation rates by Alamar Blue dye reduction assay based on the resazurin reduction test [37]. Cell proliferation was measured by quantitation of the reduction of the intracellular environment. The internal environment of the proliferating cell was attenuated compared with that of non-proliferating cells. Specifically, the ratios of NADP/NADPH, FADH/FAD, FMNH/FMN, and NADH/NAD, increase during proliferation. Alamar blue, which can be reduced by these metabolic intermediates, is useful in monitoring cell proliferation [38,39]. If N2a-Rα cells differentiate into neurons, cell growth would be reduced. The proliferation of N2a-Rα cells decreased by approximately 40% after 7 days, compared to N2a-Vc (Fig. 5). We also analysed the possibility of apoptosis in N2a-Rα cells. After 7-day culture, caspase-3/7 activities were not far differed from N2a-Vc (data not shown).

Together these results suggest that the N2a-Rα neurites may be considered to exhibit axon-like properties, and the morphological changes of N2a-Rα might be consistent with neuronal differentiation.

Effect of AhR activation on catecholaminergic differentiation

It has been demonstrated that N2a-Rα cells exhibit neuron-like morphology with neurites that display axon-like properties. To further characterize the neuronal differentiation of N2a-Rα, we examined neurotransmitter production, which is characteristic of functional neurons. We assessed the expression of tyrosine hydroxylase (TH) and Nurr-1. TH is the rate-limiting enzyme in the production of neurotransmitters and is considered an adequate marker of catecholaminergic neurons [40,41]. Nurr-1 regulates the expressions of TH mRNA [42]. It has been reported that over-expression of Nurr-1 induced neurite elongation and led to differentiation of neural stem cells to dopaminergic neurons [43-45]. The level of TH mRNAs in the N2a-Rα and N2a-Vc cells was evaluated using RT-PCR. The amount of TH mRNA in the N2a-Rα cells was approximately twice that in the N2a-Vc cells (Fig. 6A). The level of Nurr-1 mRNA in N2a-Rα and N2a-Vc cells was also examined and higher levels were detected in N2a-Rα compared to N2a-Vc (Fig. 6B). This is supporting the neuronal differentiation of N2a-Rα, including neurotransmitter production. It is very likely that N2a-Rα cells differentiated into catecholaminergic neuron-like cells, triggered by the over-expression of AhR.

Discussion

Activation of the AhR by dioxins results in the induction of xenobiotic metabolism and successive toxic responses, including hepatocellular damage, immune system disorders, reproductive system disorders, teratogenesis and carcinogenesis [46-48]. In the immune system, activated AhR suppresses a variety of B-cell mediated responses through aberrations in bone marrow B-cell development [49]. In the reproductive system, activated AhR causes depletion of fetal oocytes by apoptosis [50,51]. In response to unknown developmental cues, in addition to those stated above, the AhR can influence normal development.

In the nervous system, dioxins and related compounds are suspected to cause neurological disruption in human and experimental animal offspring following perinatal exposure during development and growth [52,53]. The perinatal period is a critical time for brain development with regard to formation of the neural network [54,55]. The dioxin receptor, AhR, is likely to participate in the developmental neurotoxicity of dioxins.

AhR-mediated pathways exist to mediate the effects of TCDD in many organs such as the liver, reproductive organs or immune tissues. [5,6]. However, in the brain, the mechanism involved in AhR-mediated transcription has been less well-elucidated. Therefore, we attempted to analyze the participation of AhR activation following exposure of the developing neuron to TCDD, by producing and using N2a-Rα cells, which were stably transfected with AhR cDNA in an undifferentiated neuroblastoma cell line, Neuro2a.

We have shown that the AhR is also functional in N2aRα cells even in the absence of ligand. This is based on the finding that the increase of CYP1A1 mRNA expression caused by over-expression of exogenous AhR was clearly suppressed by repression of the AhR with siRNA. There have been several other examples in which transfected AhR has been found to be active in the host cells [56,57], although it remains unclear why ligand-dependent AhR is activated under conditions in the absence of either ligand or TCDD.

The possible underlying mechanisms of AhR responses have been discussed previously. In many cell models, the AhR has been shown to stimulate growth arrest and apoptosis [58]. For example, in hepatocytes AhR activation promotes apoptosis in response to Fas stimulation [59]. However, AhR-induced apoptosis has not been reported in neurons, excluding the dorsal midbrain of zebrafish [60]. In this study, N2a-Rα did not give rise to cell death or apoptosis. N2a-Rα cells exhibited neuron-like features morphologically and functionally. Neurites were elongated from N2a-Rα, despite the fact that the transfectant possessed an intact vector (N2a-Vc) and the parental Neuro2a cells (Neuro2a) exhibited no process elongation. From a functional perspective, N2a-Rα cells exhibited elevation of TH mRNA, which is a selective marker of catecholaminergic neurons. These observations in N2a-Rα cells suggest that AhR over-activation in undifferentiated neurons triggered catecholaminergic neural differentiation, but not cell death. We hypothesized that the diversity of AhR toxicity may depend on AhR functions that are specific to each tissue or cell, although the physiological role of the AhR was not fully investigated.

Despite the fact that little evidence supporting the physiological function of the AhR in neural cells has been found so far, it has been reported that AhR is a member of the bHLH family transcription factor family. Although the AhR is an orphan receptor whose function has not been revealed, it is helpful for understanding AhR function to consider the relationships between AhR and other members of the bHLH family. Members of the bHLH family form a molecular-signaling network related to neural development and differentiation. For example, Hes-1 (the Hairy and Enhancer of Split homolog-1) and Hes-5 down-regulate Mash-1 and Math-1, respectively. Mash-1 and Math-1 subsequently down-regulate NeuroD and Math-2, and finally regulate the expression of nerve-specific genes [61]. In this manner, Hes-1 is known to be a key modulator in controlling neural proliferation and differentiation, but its function differs depending on the type of cells. On one hand, the AhR up-regulates Hes-1 through the XRE binding [62]. On the other hand, Hes-1 restrains neuronal differentiation and also inhibits cell proliferation in PC12 cells [63]. Although the function of Hes-1 in Neuro2a remains unknown, we hypothesize that the AhR might mediate neural development and differentiation through Hes-1 in the same manner as other members of the bHLH family gene network.

Consequently, in developing neurons, irregular or excessive activation of AhR possibly causes disrupted neural development rather than cell death. In the brain, TCDD exposure during the perinatal period may affect XRE-regulated gene expression through AhR activation and disrupt the differentiation of neurons, which are strictly regulated for developing brain formation

Conclusion

In this study, we have shown that over-expression of AhR caused neural differentiation of Neuro2a cells. Neruo2a cells transfected with AhR, named N2a-Rα, may mimic the neurons forming the neural network during the perinatal stages, expressing AhR in the presence of the ligand. The AhR is a major participant in the expression of neurotoxicity and plays a role in the structural and functional development of neural cells. We hypothesized that perinatal exposure to dioxins may disrupt the strict regulation of brain formation with irregular differentiation rather than cell death. In consequence, the decline of neural function based on excess differentiation of neurons by AhR activation may play an important role in the developmental neurotoxicity of dioxins.

Abbreviations

AhR, aryl hydrocarbon receptor

XRE, xenobiotic responsive element

TH, tyrosine hydroxylase

bHLH-PAS, basic helix-loop-helix/Per-Arnt-Sim

TCDD, 2, 3, 7, 8, -tetrachlorodibezo-p-dioxin

CYP, cytochrome P-450

FITC, fluorescein isothiocyanate

Competing interests

The author(s) declare that they have no competing interests.

Authors' contributions

EA designed the study and performed all experiments. SY was responsible for the cloning and maintenance of all cell strains constructed. MIS collaborated on experimental design, participated in data analysis, and wrote the manuscript. All authors read and approved the final manuscript.

Acknowledgements

We are grateful to Dr. K. Nakagawa and Dr. S. Itoh for their helpful comments throughout this study.

References

1. Burbach KM, Poland A, Bradfield CA: Cloning of the Ah-receptor cDNA reveals a distinctive ligand-activated transcription factor.

   Proc Natl Acad Sci USA 1992, 89:8185-8189. PubMed Abstract | Publisher Full Text | PubMed Central Full Text

2. Ema M, Sogawa K, Watanabe N, Chujoh Y, Matsushita N, Gotoh O, Funae Y, Fujii-Kuriyama Y: cDNA cloning and structure of mouse putative Ah receptor.

   Biochem Biophys Res Commun 1992, 184:246-253. PubMed Abstract | Publisher Full Text

3. Nebert DW, Roe AL, Dieter MZ, Solis WA, Yang Y, Dalton TP: Role of the aromatic hydrocarbon receptor and [Ah] gene battery in the oxidative stress response, cell cycle control, and apoptosis.

   Biochem Pharmacol 2000, 59:65-85. PubMed Abstract | Publisher Full Text

4. Machala M, Vondracek J, Blaha L, Ciganek M, Neca JV: Aryl hydrocarbon receptor-mediated activity of mutagenic polycyclic aromatic hydrocarbons determined using in vitro reporter gene assay.

   Mutat Res 2001, 497:49-62. PubMed Abstract | Publisher Full Text

5. Hankinson O: The aryl hydrocarbon receptor complex.

   Annu Rev Pharmacol Toxicol 1995, 35:307-340. PubMed Abstract | Publisher Full Text

6. Gu YZ, Hogenesch JB, Bradfield CA: The PAS superfamily: sensors of environmental and developmental signals.

   Annu Rev Pharmacol Toxicol 2000, 40:519-561. PubMed Abstract | Publisher Full Text

7. Fukunaga BN, Probst MR, Reisz-Porszasz S, Hankinson O: Identification of functional domains of the aryl hydrocarbon receptor.

   J Biol Chem 1995, 270:29270-29278. PubMed Abstract | Publisher Full Text

8. Jones PB, Durrin LK, Galeazzi DR, Whitlock JP Jr: Control of cytochrome P1-450 gene expression: analysis of a dioxin-responsive enhancer system.

   Proc Natl Acad Sci USA 1986, 83:2802-2806. PubMed Abstract | Publisher Full Text | PubMed Central Full Text

9. Fujisawa-Sehara A, Yamane M, Fujii-Kuriyama Y: A DNA-binding factor specific for xenobiotic responsive elements of P-450c gene exists as a cryptic form in cytoplasm: its possible translocation to nucleus.

   Proc Natl Acad Sci USA 1988, 85:5859-5863. PubMed Abstract | Publisher Full Text | PubMed Central Full Text

10. Neuhold LA, Shirayoshi Y, Ozato K, Jones JE, Nebert DW: Regulation of mouse CYP1A1 gene expression by dioxin: requirement of two cis-acting elements during induction.

    Mol Cell Biol 1989, 9:2378-2386. PubMed Abstract | PubMed Central Full Text

11. Fernandez-Salguero PM, Hilbert DM, Rudikoff S, Ward JM, Gonzalez FJ: Aryl-hydrocarbon receptor-deficient mice are resistant to 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced toxicity.

    Toxicol Appl Pharmacol 1996, 140:173-179. PubMed Abstract | Publisher Full Text

12. Sogawa K, Fujii-Kuriyama Y: Ah receptor, a novel ligand-activated transcription factor.

    J Biochem (Tokyo) 1997, 122:1075-1079. PubMed Abstract

13. Kolluri SK, Weiss C, Koff A, Gottlicher M: p27(Kip1) induction and inhibition of proliferation by the intracellular Ah receptor in developing thymus and hepatoma cells.

    Genes Dev 1999, 13:1742-1753. PubMed Abstract | Publisher Full Text | PubMed Central Full Text

14. Matikainen T, Perez GI, Zheng TS, Kluzak TR, Rueda BR, Flavell RA, Tilly JL: Caspase-3 gene knockout defines cell lineage specificity for programmed cell death signaling in the ovary.

    Endocrinology 2001, 142:2468-2480. PubMed Abstract | Publisher Full Text

15. Schantz SL, Seo BW, Moshtaghian J, Peterson RE, Moore RW: Effects of gestational and lactational exposure to TCDD or coplanar PCBs on spatial learning.

    Neurotoxicol Teratol 1996, 18:305-313. PubMed Abstract | Publisher Full Text

16. Seo BW, Powers BE, Widholm JJ, Schantz SL: Radial arm maze performance in rats following gestational and lactational exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).

    Neurotoxicol Teratol 2000, 22:511-519. PubMed Abstract | Publisher Full Text

17. Kakeyama M, Sone H, Miyabara Y, Tohyama C: Perinatal Exposure to 2,3,7,8-Tetrachlorodibenzo-p-Dioxin Alters Activity-Dependent Expression of BDNF mRNA in the Neocortex and male Rat Sexual Behavior in Adulthood.

    Neuro Toxicology 2003, 24:207-217.

18. Kainu T, Gustafsson J-A, Pelto-Huikko M: The dioxin receptor and its nuclear translocator (Arnt) in the rat brain.

    Neuroreport 1995, 6:2557-2560. PubMed Abstract

19. Huang P, Rannug A, Ahlbom E, Hakansson H, Ceccatelli S: Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on the expression of cytochrome P450 1A1, the aryl hydrocarbon receptor, and the aryl hydrocarbon receptor nuclear translocator in rat brain and pituitary.

    Toxicol Appl Pharmacol 2000, 169:159-167. PubMed Abstract | Publisher Full Text

20. Abbott BD, Birnbaum LS, Perdew GH: Developmental expression of two members of a new class of transcription factors: I. Expression of aryl hydrocarbon receptor in the C57BL/6N mouse embryo.

    Dev Dyn 1995, 204:133-143. PubMed Abstract

21. Abbott BD, Probst MR: Developmental expression of two members of a new class of transcription factors: II. Expression of aryl hydrocarbon receptor nuclear translocator in the C57BL/6N mouse embryo.

    Dev Dyn 1995, 204:144-155. PubMed Abstract

22. Williamson MA, Gasiewicz TA, Opanashuk LA: Aryl hydrocarbon receptor expression and activity in cerebellar granule neuroblasts: implications for development and dioxin neurotoxicity.

    Toxicol Sci 2005, 83:340-348. PubMed Abstract | Publisher Full Text

23. Castleberry RP: Neuroblastoma.

    Eur J Cancer 1997, 33:1430-1437. PubMed Abstract | Publisher Full Text

24. Wu G, Fang Y, Lu ZH, Ledeen RW: Induction of axon-like and dendrite-like processes in neuroblastoma cells.

    J Neurocytol 1998, 27:1-14. PubMed Abstract | Publisher Full Text

25. Diaz-Nido J, Armas-Portela R, Correas I, Dominguez JE, Montejo E, Avila J: Microtubule protein phosphorylation in neuroblastoma cells and neurite growth.

    J Cell Sci Suppl 1991, 15:51-59. PubMed Abstract

26. Cortes-Canteli M, Pignatelli M, Santos A, Perez-Castillo A: CCAAT/enhancer-binding protein beta plays a regulatory role in differentiation and apoptosis of neuroblastoma cells.

    J Biol Chem 2002, 277:5460-5467. PubMed Abstract | Publisher Full Text

27. Mitsui K, Tsuji S, Yamazaki M, Nagai Y: Multiple neurite formation in neuroblastoma cell lines by griseolic acid, a potent inhibitor of cyclic nucleotide phosphodiesterases.

    J Neurochem 1991, 57:556-561. PubMed Abstract

28. Image J Image processing and analysis in Jawa [http://rsb.info.nih.gov/ij] webcite

29. Baba T, Mimura J, Gradin K, Kuroiwa A, Watanabe T, Matsuda Y, Inazawa J, Sogawa K, Fujii-Kuriyama Y: Structure and expression of the Ah receptor repressor gene.

    J Biol Chem 2001, 276:33101-33110. PubMed Abstract | Publisher Full Text

30. Kobayashi A, Sogawa K, Fujii-Kuriyama Y: Cooperative interaction between AhR.Arnt and Sp1 for the drug-inducible expression of CYP1A1 gene.

    J Biol Chem 1996, 271:12310-12316. PubMed Abstract | Publisher Full Text

31. Mao AJ, Bechberger J, Lidington D, Galipeau J, Laird DW, Naus CC: Neuronal differentiation and growth control of neuro-2a cells after retroviral gene delivery of connexin43.

    J Biol Chem 2000, 275:34407-34414. PubMed Abstract | Publisher Full Text

32. Hargreaves A, Yusta B, Aranda A, Avila J, Pascual A: Triiodothyronine (T3) induces neurite formation and increases synthesis of a protein related to MAP 1B in cultured cells of neuronal origin.

    Brain Res 1988, 466:141-148. PubMed Abstract

33. Li X, Saint-Cyr-Proulx E, Aktories K, Lamarche-Vane N: Rac1 and Cdc42 but not RhoA or Rho kinase activities are required for neurite outgrowth induced by the Netrin-1 receptor DCC (deleted in colorectal cancer) in N1E-115 neuroblastoma cells.

    J Biol Chem 2002, 277:15207-15214. PubMed Abstract | Publisher Full Text

34. Causeret F, Hidalgo-Sanchez M, Fort P, Backer S, Popoff MR, Gauthier-Rouviere C, Bloch-Gallego E: Distinct roles of Rac1/Cdc42 and Rho/Rock for axon outgrowth and nucleokinesis of precerebellar neurons toward netrin 1.

    Development 2004, 131:2841-2852. PubMed Abstract | Publisher Full Text

35. Ahmed I, Calle Y, Iwashita S, Nur EKA: Role of Cdc42 in neurite outgrowth of PC12 cells and cerebellar granule neurons.

    Mol Cell Biochem 2006, 281:17-25. PubMed Abstract | Publisher Full Text

36. Kim MD, Kolodziej P, Chiba A: Growth cone pathfinding and filopodial dynamics are mediated separately by Cdc42 activation.

    J Neurosci 2002, 22:1794-1806. PubMed Abstract | Publisher Full Text

37. O'Brien J, Wilson I, Orton T, Pognan F: Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity.

    Eur J Biochem 2000, 267:5421-5426. PubMed Abstract | Publisher Full Text

38. Larson EM, Doughman DJ, Gregerson DS, Obritsch WF: A new, simple, nonradioactive, nontoxic in vitro assay to monitor corneal endothelial cell viability.

    Invest Ophthalmol Vis Sci 1997, 38:1929-1933. PubMed Abstract

39. White MJ, DiCaprio MJ, Greenberg DA: Assessment of neuronal viability with Alamar blue in cortical and granule cell cultures.

    J Neurosci Methods 1996, 70:195-200. PubMed Abstract | Publisher Full Text

40. Tillet Y, Thibault J: Catecholamine-containing neurons in the sheep brainstem and diencephalon: immunohistochemical study with tyrosine hydroxylase (TH) and dopamine-beta-hydroxylase (DBH) antibodies.

    J Comp Neurol 1989, 290:69-104. PubMed Abstract | Publisher Full Text

41. Kastner A, Hirsch EC, Agid Y, Javoy-Agid F: Tyrosine hydroxylase protein and messenger RNA in the dopaminergic nigral neurons of patients with Parkinson's disease.

    Brain Res 1993, 606:341-345. PubMed Abstract | Publisher Full Text

42. Kim KS, Kim CH, Hwang DY, Seo H, Chung S, Hong SJ, Lim JK, Anderson T, Isacson O: Orphan nuclear receptor Nurr1 directly transactivates the promoter activity of the tyrosine hydroxylase gene in a cell-specific manner.

    J Neurochem 2003, 85:622-634. PubMed Abstract

43. Wagner J, Akerud P, Castro DS, Holm PC, Canals JM, Snyder EY, Perlmann T, Arenas E: Induction of a midbrain dopaminergic phenotype in Nurr1-overexpressing neural stem cells by type 1 astrocytes.

    Nat Biotechnol 1999, 17:653-659. PubMed Abstract | Publisher Full Text

44. Saucedo-Cardenas O, Quintana-Hau JD, Le WD, Smidt MP, Cox JJ, De Mayo F, Burbach JP, Conneely OM: Nurr1 is essential for the induction of the dopaminergic phenotype and the survival of ventral mesencephalic late dopaminergic precursor neurons.

    Proc Natl Acad Sci USA 1998, 95:4013-4018. PubMed Abstract | Publisher Full Text | PubMed Central Full Text

45. Joseph B, Wallen-Mackenzie A, Benoit G, Murata T, Joodmardi E, Okret S, Perlmann T: p57(Kip2) cooperates with Nurr1 in developing dopamine cells.

    Proc Natl Acad Sci USA 2003, 100:15619-15624. PubMed Abstract | Publisher Full Text | PubMed Central Full Text

46. Birnbaum LS, Tuomisto J: Non-carcinogenic effects of TCDD in animals.

    Food Addit Contam 2000, 17:275-288. PubMed Abstract | Publisher Full Text

47. Walisser JA, Glover E, Pande K, Liss AL, Bradfield CA: Aryl hydrocarbon receptor-dependent liver development and hepatotoxicity are mediated by different cell types.

    Proc Natl Acad Sci USA 2005, 102:17858-17863. PubMed Abstract | Publisher Full Text | PubMed Central Full Text

48. Jensen BA, Leeman RJ, Schlezinger JJ, Sherr DH: Aryl hydrocarbon receptor (AhR) agonists suppress interleukin-6 expression by bone marrow stromal cells: an immunotoxicology study.

    Environ Health 2003, 2:16-29. PubMed Abstract | BioMed Central Full Text | PubMed Central Full Text

49. Allan LL, Sherr DH: Constitutive activation and environmental chemical induction of the aryl hydrocarbon receptor/transcription factor in activated human B lymphocytes.

    Mol Pharmacol 2005, 67:1740-1750. PubMed Abstract | Publisher Full Text

50. Shiromizu K, Mattison DR: Murine oocyte destruction following intraovarian treatment with 3-methylcholanthrene or 7,12-dimethylbenz(a)anthracene: protection by alpha-naphthoflavone.

    Teratog Carcinog Mutagen 1985, 5:463-472. PubMed Abstract | Publisher Full Text

51. Matikainen TM, Moriyama T, Morita Y, Perez GI, Korsmeyer SJ, Sherr DH, Tilly JL: Ligand activation of the aromatic hydrocarbon receptor transcription factor drives Bax-dependent apoptosis in developing fetal ovarian germ cells.

    Endocrinology 2002, 143:615-620. PubMed Abstract | Publisher Full Text

52. Thiel R, Koch E, Ulbrich B, Chahoud I: Peri- and postnatal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin: effects on physiological development, reflexes, locomotor activity and learning behaviour in Wistar rats.

    Arch Toxicol 1994, 69:79-86. PubMed Abstract | Publisher Full Text

53. Kakeyama M, Tohyama C: Developmental Neurotoxicity of Dioxin and Its Related Compounds.

    Industrial Health 2003, 41:215-230. PubMed Abstract

54. Herlenius E, Lagercrantz H: Development of neurotransmitter systems during critical periods.

    Exp Neurol 2004, 190:8-21. Publisher Full Text

55. Viveros MP, Llorente R, Moreno E, Marco EM: Behavioural and neuroendocrine effects of cannabinoids in critical developmental periods.

    Behav Pharmacol 2005, 16:353-362. PubMed Abstract | Publisher Full Text

56. Kazlauskas A, Poellinger L, Pongratz I: Evidence That the Co-chaperone p23 Regulates Ligand Responsiveness of the Dioxin (Aryl Hydrocarbon) Receptor.

    J Biol Chem 1999, 274:13159-13254. Publisher Full Text

57. Petrulis JR, kusnadi A, Ramadoss P, Hollingshead B, Perdew GH: The hsp90 Co-chaperone XAP2 Alters Importin fÀ Recognition of the Bipartite Nuclear Localization Signal of the Ah receptor and Repress Transcriptional Activity.

    J Biol Chem 2003, 278:2677-2685. PubMed Abstract | Publisher Full Text

58. Ahmed S, Shibazaki M, Takeuchi T, Kikuchi H: Protein kinase Ctheta activity is involved in the 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced signal transduction pathway leading to apoptosis in L-MAT, a human lymphoblastic T-cell line.

    Febs J 2005, 272:903-915. PubMed Abstract | Publisher Full Text

59. Park KT, Mitchell KA, Huang G, Elferink CJ: The aryl hydrocarbon receptor predisposes hepatocytes to Fas-mediated apoptosis.

    Mol Pharmacol 2005, 67:612-622. PubMed Abstract | Publisher Full Text

60. Dong W, Teraoka H, Yamazaki K, Tsukiyama S, Imani S, Imagawa T, Stegeman JJ, Peterson RE, Hiraga T: 2,3,7,8-tetrachlorodibenzo-p-dioxin toxicity in the zebrafish embryo: local circulation failure in the dorsal midbrain is associated with increased apoptosis.

    Toxicol Sci 2002, 69:191-201. PubMed Abstract | Publisher Full Text

61. Ohtsuka T, Asahi M, Matsuura N, Kikuchi H, Hojo M, Kageyama R, Ohkubo H, Hoshimaru M: Regulated expression of neurogenic basic helix-loop-helix transcription factors during differentiation of the immortalized neuronal progenitor cell line HC2S2 into neurons.

    Cell Tissue Res 1998, 293:23-29. PubMed Abstract | Publisher Full Text

62. Thomsen JS, Kietz S, Strom A, Gustafsson JA: HES-1, a novel target gene for the aryl hydrocarbon receptor.

    Mol Pharmacol 2004, 65:165-171. PubMed Abstract | Publisher Full Text

63. Castella P, Sawai S, Nakao K, Wagner JA, Caudy M: HES-1 repression of differentiation and proliferation in PC12 cells: role for the helix 3-helix 4 domain in transcription repression.

    Mol Cell Biol 2000, 20:6170-6183. PubMed Abstract | Publisher Full Text | PubMed Central Full Text

Have something to say? Post a comment on this article!